An international multidisciplinary consensus statement on MAFLD and the risk of CVD
© Asian Pacific Association for the Study of the Liver 2023 Background: Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysf...
Saved in:
| Published in | Hepatology International Vol. 17; no. 4; pp. 773 - 791 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Delhi
Springer Science and Business Media LLC
01.08.2023
Springer Springer India Springer Nature B.V Springer Internat. Publ |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1936-0533 1936-0541 1936-0541 |
| DOI | 10.1007/s12072-023-10543-8 |
Cover
| Abstract | © Asian Pacific Association for the Study of the Liver 2023
Background: Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists. Methods and results: A multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management. Conculsions: The expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research. |
|---|---|
| AbstractList | Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists.BACKGROUNDFatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists.A multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management.METHODS AND RESULTSA multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management.The expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research.CONCULSIONSThe expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research. Background Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25–30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists. Methods and results A multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management. Conculsions The expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research. © Asian Pacific Association for the Study of the Liver 2023 Background: Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists. Methods and results: A multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management. Conculsions: The expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research. BackgroundFatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25–30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists.Methods and resultsA multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management.ConculsionsThe expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research. Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists. A multidisciplinary panel of fifty-two international experts comprising Hepatologists, Endocrinologists, Diabetologists, Cardiologists and Family Physicians from six continents (Asia, Europe, North America, South America, Africa and Oceania) participated in a formal Delphi survey and developed consensus statements on the association between MAFLD and the risk of CVD. Statements were developed on different aspects of CVD risk, ranging from epidemiology to mechanisms, screening, and management. The expert panel identified important clinical associations between MAFLD and the risk of CVD that could serve to increase awareness of the adverse metabolic and cardiovascular outcomes of MAFLD. Finally, the expert panel also suggests potential areas for future research. |
| Author | Eslam, Mohammed Cai, Jingjing Somers, Virend Cortez-Pinto, Helena Ryan, John D. Papatheodoridis, George V. Kim, Seung Up de Knegt, Robert J. Huang, Yuli Sebastiani, Giada Ikonomidis, Ignatios Ghazinyan, Hasmik Steg, Philippe Gabriel Sun, Aijun Pastori, Daniele Nguyen, Mindie H. Zheng, Ming-Hua Li, Jian-Jun Zhou, Xiao-Dong Huang, Hui Yilmaz, Yusuf Targher, Giovanni Méndez-Sánchez, Nahum Alqahtani, Saleh A. Sung, Ki-Chul Hamaguchi, Masahide Byrne, Christopher D. Fan, Jian-Gao Wong, Vincent Wai-Sun Chahal, C. Anwar A. Hamid, Saeed Chan, Wah Kheong Treeprasertsuk, Sombat Lupsor-Platon, Monica Tilg, Herbert Perera, Nilanka Misra, Anoop Shapiro, Michael D. Fudim, Marat Ocama, Ponsiano Brotons, Carlos Romero-Gomez, Manuel Boursier, Jerome Son, Jang Won Goh, George Boon-Bee George, Jacob Lip, Gregory Y. H. Al Mahtab, Mamun |
| Author_xml | – sequence: 1 orcidid: 0000-0002-8534-0818 fullname: Zhou, Xiao-Dong – sequence: 2 fullname: Targher, Giovanni – sequence: 3 orcidid: 0000-0001-6322-7753 fullname: Byrne, Christopher D – sequence: 4 fullname: Somers, Virend – sequence: 5 orcidid: 0000-0002-9658-8050 fullname: Kim, Seung Up – sequence: 6 fullname: Chahal, C Anwar A – sequence: 7 fullname: Wong, Vincent Wai-Sun – sequence: 8 fullname: Cai, Jingjing – sequence: 9 fullname: Shapiro, Michael D – sequence: 10 fullname: Eslam, Mohammed – sequence: 11 fullname: Steg, Philippe Gabriel – sequence: 12 fullname: Sung, Ki-Chul – sequence: 13 fullname: Misra, Anoop – sequence: 14 fullname: Li, Jian-Jun – sequence: 15 fullname: Brotons, Carlos – sequence: 16 fullname: Huang, Yuli – sequence: 17 fullname: Papatheodoridis, George V – sequence: 18 fullname: Sun, Aijun – sequence: 19 orcidid: 0000-0003-4518-5283 fullname: Yilmaz, Yusuf – sequence: 20 fullname: Chan, Wah Kheong – sequence: 21 fullname: Huang, Hui – sequence: 22 fullname: Méndez-Sánchez, Nahum – sequence: 23 orcidid: 0000-0003-2017-3526 fullname: Alqahtani, Saleh A – sequence: 24 orcidid: 0000-0002-8537-8744 fullname: Cortez-Pinto, Helena – sequence: 25 fullname: Lip, Gregory Y H – sequence: 26 fullname: de Knegt, Robert J – sequence: 27 fullname: Ocama, Ponsiano – sequence: 28 fullname: Romero-Gomez, Manuel – sequence: 29 orcidid: 0000-0002-8671-7007 fullname: Fudim, Marat – sequence: 30 fullname: Sebastiani, Giada – sequence: 31 fullname: Son, Jang Won – sequence: 32 orcidid: 0000-0002-2805-8808 fullname: Ryan, John D – sequence: 33 fullname: Ikonomidis, Ignatios – sequence: 34 orcidid: 0000-0001-6459-8329 fullname: Treeprasertsuk, Sombat – sequence: 35 fullname: Pastori, Daniele – sequence: 36 orcidid: 0000-0001-7918-1956 fullname: Lupsor-Platon, Monica – sequence: 37 fullname: Tilg, Herbert – sequence: 38 fullname: Ghazinyan, Hasmik – sequence: 39 fullname: Boursier, Jerome – sequence: 40 fullname: Hamaguchi, Masahide – sequence: 41 fullname: Nguyen, Mindie H – sequence: 42 fullname: Fan, Jian-Gao – sequence: 43 fullname: Goh, George Boon-Bee – sequence: 44 fullname: Al Mahtab, Mamun – sequence: 45 fullname: Hamid, Saeed – sequence: 46 orcidid: 0000-0003-0154-1864 fullname: Perera, Nilanka – sequence: 47 orcidid: 0000-0002-6592-3215 fullname: George, Jacob – sequence: 48 orcidid: 0000-0003-4984-2631 fullname: Zheng, Ming-Hua |
| BackLink | https://cir.nii.ac.jp/crid/1871428067839517440$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/37204656$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-04214717$$DView record in HAL |
| BookMark | eNp9kktv1DAUhSPUipbSP8ACGcGCLgK-fmeFRlNKkQax4LG1nMTpGDL21E5G4t_jNGWAWXST53fuPb7nPimOfPC2KJ4BfgMYy7cJCJakxISWgDmjpXpUnEJFRZnf4Gj_TOlJcZ6SqzEFIijj9HFxQiXBTHBxWnxZeOT8YKM3gwve9Ggz9oNrXWrctnfexF-oCT5Zn8aE0mAGu7F-QMGjT4ur1SUyvkXD2qLo0k8UOrT8fvm0OO5Mn-z5_f2s-Hb1_uvyulx9_vBxuViVjaB4KDkY0YnKMtWKmivbgOksaxvgjegq21nCayI4bUFIRVuhpBJCMYzrriMqH_mseDfX3Y71xrZN9hVNr7fRbbJtHYzT___xbq1vwk4DhkphOlW4mCusD3TXi5WevmFGgEmQO8js6_tuMdyONg16k4dk-954G8akico-hchhZPTlAfojjHnC_UQxyiXNsWXq-b_29_3_hJMBMgNNDClF2-0RwHpaAj0vgc7V9N0SaJVF6kDUuOEu2zwC1z8spbM05T7-xsa_th9UvZhVsTFmq6Pdubwmk4Rx0FxyOZ3k1cx457Kf6QpKAiMKT9lWHCRjmP4GsKzYlQ |
| CitedBy_id | crossref_primary_10_1016_j_jhep_2024_03_039 crossref_primary_10_1016_j_jhepr_2025_101372 crossref_primary_10_1016_j_metabol_2024_156028 crossref_primary_10_1016_j_aohep_2023_101138 crossref_primary_10_1016_j_cpcardiol_2024_102569 crossref_primary_10_1111_liv_15799 crossref_primary_10_1111_liv_70058 crossref_primary_10_1007_s12072_024_10745_8 crossref_primary_10_3389_fnut_2024_1355732 crossref_primary_10_1002_hsr2_2102 crossref_primary_10_1016_j_dsx_2025_103209 crossref_primary_10_20517_2394_5079_2024_63 crossref_primary_10_1016_j_nucmedbio_2025_108997 crossref_primary_10_3350_cmh_2023_0315 crossref_primary_10_1007_s13679_024_00582_z crossref_primary_10_3390_jcm13164657 crossref_primary_10_1016_j_scib_2024_01_006 crossref_primary_10_1016_j_cmet_2024_04_020 crossref_primary_10_1161_JAHA_124_037081 crossref_primary_10_1007_s12072_024_10774_3 crossref_primary_10_3390_ijms25073694 crossref_primary_10_1016_j_acra_2024_10_027 crossref_primary_10_2147_DMSO_S486841 crossref_primary_10_1136_gutjnl_2024_333074 crossref_primary_10_3390_biology13070519 crossref_primary_10_1039_D3TB01921G crossref_primary_10_1186_s12916_024_03502_z crossref_primary_10_57105_2415_7252_2023_5_01 crossref_primary_10_1371_journal_pone_0316997 crossref_primary_10_4254_wjh_v17_i3_102286 crossref_primary_10_1007_s12072_024_10711_4 crossref_primary_10_1016_j_diabet_2023_101506 crossref_primary_10_31832_smj_1636384 crossref_primary_10_1016_j_numecd_2024_10_007 crossref_primary_10_1016_j_tem_2024_05_009 crossref_primary_10_3390_biomedicines12030692 crossref_primary_10_1080_14656566_2024_2312239 crossref_primary_10_1016_j_eclinm_2024_102848 crossref_primary_10_1136_gutjnl_2023_331003 crossref_primary_10_1007_s11886_024_02025_6 crossref_primary_10_1136_gutjnl_2023_330595 crossref_primary_10_1016_j_medj_2024_03_017 crossref_primary_10_1155_2023_2736630 crossref_primary_10_1016_j_tjnut_2024_04_016 crossref_primary_10_1111_liv_15931 crossref_primary_10_1161_JAHA_123_032997 crossref_primary_10_1111_dom_15709 crossref_primary_10_1097_CP9_0000000000000106 crossref_primary_10_1111_liv_16025 crossref_primary_10_59717_j_xinn_med_2024_100064 crossref_primary_10_1007_s12072_024_10702_5 crossref_primary_10_1111_apt_17660 crossref_primary_10_1186_s12933_023_02014_z crossref_primary_10_1007_s12072_024_10660_y crossref_primary_10_1038_s41598_024_63453_6 crossref_primary_10_1186_s12933_024_02432_7 crossref_primary_10_1124_pharmrev_123_001087 crossref_primary_10_1016_j_jhepr_2024_101313 crossref_primary_10_1016_j_isci_2024_109431 crossref_primary_10_3390_nu16060866 crossref_primary_10_7570_jomes23052 crossref_primary_10_1016_j_tem_2024_02_007 crossref_primary_10_1186_s12876_024_03525_z crossref_primary_10_1210_clinem_dgad749 crossref_primary_10_1097_CP9_0000000000000067 crossref_primary_10_1038_s44355_024_00004_w crossref_primary_10_1016_j_bios_2024_117077 crossref_primary_10_1007_s12072_024_10731_0 crossref_primary_10_1016_j_clnu_2024_11_016 |
| Cites_doi | 10.1016/j.jhep.2020.03.039 10.1016/S0140-6736(10)61272-X 10.1053/j.gastro.2016.12.020 10.1016/j.jhep.2019.03.033 10.21037/hbsn-21-352 10.1016/j.cgh.2019.12.026 10.1038/ejcn.2010.61 10.3389/fmed.2021.693507 10.1053/j.gastro.2012.02.003 10.1038/srep33386 10.3748/wjg.v20.i2.569 10.1016/j.metabol.2021.154779 10.1161/CIRCRESAHA.119.316337 10.3390/nu14010103 10.5009/gnl210167 10.1001/jama.2021.19569 10.1016/S0140-6736(18)30134-X 10.1136/gutjnl-2020-320622 10.1111/jgh.15589 10.1053/j.gastro.2015.04.005 10.1111/liv.15142 10.1016/j.jacc.2019.11.036 10.3389/fendo.2022.935390 10.1002/hep.28431 10.1002/hep.30320 10.1016/j.dld.2021.01.014 10.1016/j.jacc.2019.03.024 10.3390/nu12061732 10.3390/metabo11020073 10.1016/j.cgh.2022.10.039 10.3389/fendo.2022.1007171 10.1186/s12944-021-01440-w 10.1001/jamanetworkopen.2022.35003 10.1007/s10620-022-07508-6 10.1016/j.cgh.2018.01.026 10.3389/fendo.2022.968766 10.1038/ajg.2017.371 10.1111/jgh.14794 10.1016/j.cgh.2014.10.008 10.1016/j.cgh.2020.07.030 10.1002/hep.32294 10.1371/journal.pone.0245762 10.1136/gut.2009.203166 10.1007/s12072-022-10319-6 10.1038/s41591-023-02242-6 10.1186/s12933-022-01483-y 10.1038/s41591-020-0803-x 10.1038/s41575-018-0010-0 10.1016/j.cgh.2021.09.021 10.1016/j.cca.2017.01.008 10.1186/s12933-018-0762-4 10.1016/j.jhep.2020.12.016 10.5551/jat.Er19356 10.1177/03000605211047074 10.1161/01.CIR.82.2.495 10.1016/j.cgh.2020.12.022 10.3390/jcm10030467 10.1038/s41598-019-47687-3 10.3389/fendo.2022.957245 10.3390/nu12092762 10.3390/jcm11071847 10.3390/ijms22052350 10.1136/gutjnl-2022-328224 10.1136/bmjopen-2021-049767 10.1038/s41575-020-0269-9 10.1001/jamanetworkopen.2022.3849 10.1016/j.alcohol.2020.07.010 10.1053/j.gastro.2017.08.012 10.1002/hep.24283 10.1111/liv.15013 10.1016/S2213-8587(17)30412-6 10.1016/j.jhep.2015.11.004 10.1016/j.dld.2020.10.014 10.3389/fendo.2022.934225 10.1097/CM9.0000000000001513 10.1111/liv.14739 10.1053/j.gastro.2019.11.312 10.1056/NEJMra0912063 10.1016/S2468-1253(22)00127-3 10.1136/bmj.m4747 10.1016/j.metabol.2020.154433 10.1038/s41575-021-00523-4 10.1016/j.jacc.2021.11.007 10.1161/CIRCULATIONAHA.118.034763 10.1210/jc.2011-2260 10.1161/CIRCRESAHA.120.316242 10.1016/j.dld.2020.12.123 10.1161/ATVBAHA.122.318661 10.1038/s41574-020-0392-2 10.1016/j.cgh.2020.10.046 10.1016/S2213-8587(19)30249-9 10.1016/j.jacc.2018.11.050 10.1038/ng.3977 10.1016/S1470-2045(22)00606-4 10.1002/hep4.1183 10.1002/hep4.1723 10.1016/j.dld.2021.02.003 10.1186/s12933-022-01697-0 10.3350/cmh.2021.0406 10.1002/hep.30170 10.1007/s10620-019-5477-1 10.1155/2022/9479456 10.1002/hep.30163 10.1055/s-0038-1675357 10.1016/S2468-1253(21)00020-0 10.5009/gnl210290 10.1007/s00125-013-2898-9 10.1016/j.cgh.2021.05.029 10.1055/s-0035-1562947 10.4254/wjh.v4.i12.327 10.1056/NEJMoa2028395 10.1007/s11684-021-0888-8 10.3389/fgene.2022.971484 10.1111/1753-0407.12833 10.1001/jama.2020.12567 10.1007/s10620-021-06954-y 10.1111/liv.12611 10.1007/s12020-019-02070-0 10.1097/CM9.0000000000000981 10.1056/NEJMoa060326 10.1016/j.jhep.2016.05.013 10.1016/j.jhep.2021.07.035 10.1161/CIRCULATIONAHA.118.038868 10.3390/metabo11010022 10.1161/CIRCULATIONAHA.116.024863 10.1038/s41575-020-0316-6 10.4093/dmj.2022.0048 10.1016/j.clinre.2021.101816 10.1016/S0140-6736(15)00803-X 10.1002/hep4.1155 10.1016/j.jceh.2019.02.005 10.1016/j.jhep.2019.10.003 10.1111/hepr.13685 10.1007/s00535-021-01828-6 10.1002/hep.29367 10.5114/amsad.2020.95651 10.3390/biomedicines9121853 10.1097/MEG.0000000000001135 10.1111/bcp.14943 10.1371/journal.pone.0269265 10.1016/j.jacc.2010.01.006 10.3390/ijms222111629 10.1007/s00535-019-01649-8 10.1007/s12072-020-10094-2 10.1007/s12072-021-10252-0 10.1002/hep.29055 10.1016/S2468-1253(21)00308-3 10.1007/s13340-018-0360-4 10.1016/j.amepre.2005.01.011 10.1016/j.jacbts.2021.04.001 10.1016/j.tem.2022.03.005 10.1016/j.jacc.2019.11.031 10.1210/clinem/dgab641 |
| ContentType | Journal Article |
| Contributor | Hémodynamique, Interaction Fibrose et Invasivité tumorales Hépatiques (HIFIH) ; Université d'Angers (UA) Zhou X., Targher G., Byrne C. D., Somers V., Kim S. U., Chahal C. A. A., Wong V. W., Cai J., Shapiro M. D., Eslam M., et al Repositório da Universidade de Lisboa |
| Contributor_xml | – sequence: 1 fullname: Hémodynamique, Interaction Fibrose et Invasivité tumorales Hépatiques (HIFIH) ; Université d'Angers (UA) – sequence: 2 fullname: Repositório da Universidade de Lisboa – sequence: 3 fullname: Zhou X., Targher G., Byrne C. D., Somers V., Kim S. U., Chahal C. A. A., Wong V. W., Cai J., Shapiro M. D., Eslam M., et al |
| Copyright | Asian Pacific Association for the Study of the Liver 2023 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. Asian Pacific Association for the Study of the Liver. Asian Pacific Association for the Study of the Liver 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Distributed under a Creative Commons Attribution 4.0 International License Asian Pacific Association for the Study of the Liver 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| Copyright_xml | – notice: Asian Pacific Association for the Study of the Liver 2023 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. Asian Pacific Association for the Study of the Liver. – notice: Asian Pacific Association for the Study of the Liver 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: Asian Pacific Association for the Study of the Liver 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| DBID | RYH RCLKO AAYXX CITATION NPM 7U7 C1K K9. NAPCQ 7X8 1XC 5PM |
| DOI | 10.1007/s12072-023-10543-8 |
| DatabaseName | CiNii Complete RCAAP open access repository CrossRef PubMed Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DissertationSchool | Repositório da Universidade de Lisboa |
| EISSN | 1936-0541 |
| EndPage | 791 |
| ExternalDocumentID | PMC10198034 oai_HAL_hal_04214717v1 37204656 10_1007_s12072_023_10543_8 10451_57576 |
| Genre | Journal Article |
| GroupedDBID | --- .86 .VR 06C 06D 0R~ 0VY 1N0 203 29I 29~ 2J2 2JN 2KG 2KM 2LR 2~H 30V 4.4 406 408 40D 53G 5GY 5VS 67Z 6NX 7RV 7X7 8TC 8UJ 95- 95. 95~ 96X AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AAPKM AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACCUX ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACSTC ACZOJ ADBBV ADHHG ADHIR ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHWEU AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ATHPR AXYYD AYFIA B-. BAWUL BGNMA CS3 CSCUP DDRTE DIK DNIVK DPUIP DU5 E3Z EBLON EBS EIOEI ESBYG EX3 F5P FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GX1 HF~ HG6 HMJXF HRMNR IJ- IKXTQ IMOTQ IWAJR IXD IZQ J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- NPVJJ NQJWS NU0 O93 O9I O9J P9S PF0 PROAC PT4 QOR QOS R89 R9I ROL RPM RPX RSV RYH S16 S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TR2 TSG TSK TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 WOW YLTOR Z45 ZMTXR ZOVNA ~A9 -Y2 2VQ 88E 8AO 8FI 8FJ AANXM AARHV ABRTQ ABULA ABUWG AEBTG AFKRA AHSBF AJBLW AOIJS BDATZ BENPR BKEYQ BPHCQ BVXVI CAG CCPQU COF EJD EN4 FINBP FSGXE FYUFA H13 HMCUK HYE HZ~ M1P NAPCQ O9- OK1 PHGZM PHGZT PJZUB PPXIY PQQKQ PSQYO RCLKO S1Z UKHRP AAYXX CITATION -5E -5G -BR -EM -~C 3V. AAAVM ADINQ GQ6 NPM Z7U Z87 7U7 C1K K9. 7X8 1XC PUEGO 5PM |
| ID | FETCH-LOGICAL-c630t-51a6f69e48d6b58ec1afe4dc15c6f9efe25b2653d16783d6878668400bff28543 |
| IEDL.DBID | U2A |
| ISSN | 1936-0533 1936-0541 |
| IngestDate | Thu Aug 21 18:36:50 EDT 2025 Fri Sep 12 12:30:56 EDT 2025 Fri Sep 05 04:25:53 EDT 2025 Wed Sep 17 23:57:31 EDT 2025 Wed Feb 19 02:24:23 EST 2025 Tue Jul 01 05:06:17 EDT 2025 Thu Apr 24 22:56:29 EDT 2025 Wed Apr 09 21:52:51 EDT 2025 Fri Aug 01 16:26:43 EDT 2025 Thu Jun 26 23:59:00 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Delphi survey MAFLD Metabolic (dysfunction)-associated fatty liver disease Cardiovascular disease Non-alcoholic fatty liver disease Consensus |
| Language | English |
| License | 2023. Asian Pacific Association for the Study of the Liver. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c630t-51a6f69e48d6b58ec1afe4dc15c6f9efe25b2653d16783d6878668400bff28543 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-8534-0818 0000-0001-7918-1956 0000-0002-8537-8744 0000-0001-6459-8329 0000-0002-6592-3215 0000-0002-8671-7007 0000-0001-6322-7753 0000-0003-4518-5283 0000-0003-0154-1864 0000-0003-2017-3526 0000-0002-9658-8050 0000-0002-2805-8808 0000-0003-4984-2631 0000-0001-6896-2941 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC10198034 |
| PMID | 37204656 |
| PQID | 2843573023 |
| PQPubID | 1486344 |
| PageCount | 19 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10198034 hal_primary_oai_HAL_hal_04214717v1 proquest_miscellaneous_2816766105 proquest_journals_2843573023 pubmed_primary_37204656 crossref_primary_10_1007_s12072_023_10543_8 crossref_citationtrail_10_1007_s12072_023_10543_8 springer_journals_10_1007_s12072_023_10543_8 rcaap_revistas_10451_57576 nii_cinii_1871428067839517440 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-08-01 |
| PublicationDateYYYYMMDD | 2023-08-01 |
| PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New Delhi |
| PublicationPlace_xml | – name: New Delhi – name: United States – name: Tokyo |
| PublicationTitle | Hepatology International |
| PublicationTitleAbbrev | Hepatol Int |
| PublicationTitleAlternate | Hepatol Int |
| PublicationYear | 2023 |
| Publisher | Springer Science and Business Media LLC Springer Springer India Springer Nature B.V Springer Internat. Publ |
| Publisher_xml | – name: Springer Science and Business Media LLC – name: Springer – name: Springer India – name: Springer Nature B.V – name: Springer Internat. Publ |
| References | J Lazarus (10543_CR16) 2022; 19 H Liu (10543_CR58) 2021; 15 J Wang (10543_CR55) 2022; 16 NS Choudhary (10543_CR98) 2019; 9 M Witkowski (10543_CR96) 2020; 127 V Jacques (10543_CR146) 2021; 5 F Baratta (10543_CR112) 2017; 112 E Vilar-Gomez (10543_CR153) 2015; 149 M Eslam (10543_CR5) 2020; 158 KI Zheng (10543_CR6) 2020; 133 F Angelico (10543_CR40) 2021; 53 T Kessler (10543_CR87) 2021; 6 NR Zaidi (10543_CR100) 2020; 5 K Cusi (10543_CR72) 2012; 142 T Noda (10543_CR59) 2022; 11 M Borges-Canha (10543_CR64) 2019; 66 M Siddiqui (10543_CR71) 2015; 13 SL Kristensen (10543_CR129) 2019; 7 VG Athyros (10543_CR149) 2010; 376 M Das (10543_CR15) 2022; 23 K Drożdż (10543_CR89) 2021; 14 H Jarvis (10543_CR119) 2022; 12 R Belfort (10543_CR141) 2006; 355 DQ Sun (10543_CR13) 2021; 115 A Mantovani (10543_CR23) 2021; 6 TA Zelniker (10543_CR137) 2020; 75 MA Bethel (10543_CR130) 2018; 6 F Lei (10543_CR62) 2022; 13 X Zhang (10543_CR79) 2022; 76 W Chan (10543_CR11) 2022; 42 A Mantovani (10543_CR68) 2022; 79 V Pandyarajan (10543_CR103) 2019; 15 H Gong (10543_CR61) 2021; 49 J Yan (10543_CR128) 2019; 69 S Zelber-Sagi (10543_CR104) 2021; 53 DE Arterburn (10543_CR154) 2020; 324 H Kim (10543_CR25) 2022; 67 N Tamaki (10543_CR43) 2021; 36 R Bessho (10543_CR54) 2022; 17 G Targher (10543_CR22) 2021; 6 J Parkes (10543_CR47) 2010; 59 TY Wang (10543_CR8) 2021; 10 A Mantovani (10543_CR133) 2021; 11 Y Wang (10543_CR28) 2022; 13 A Mantovani (10543_CR37) 2022 TS Naimi (10543_CR123) 2005; 28 KJ Biddinger (10543_CR124) 2022; 5 D Liu (10543_CR86) 2017; 49 G Hassen (10543_CR99) 2022; 14 J Rivera-Esteban (10543_CR107) 2021; 41 MJ Armstrong (10543_CR131) 2016; 387 J Aron-Wisnewsky (10543_CR94) 2020; 17 LH Young (10543_CR143) 2018; 138 A Aminian (10543_CR155) 2021; 326 R Decoin (10543_CR63) 2022; 13 P Portillo-Sanchez (10543_CR145) 2019; 11 Q Huang (10543_CR26) 2021; 8 D Pastori (10543_CR148) 2022; 88 S Costanzo (10543_CR120) 2010; 55 N Chalasani (10543_CR2) 2018; 67 G Targher (10543_CR33) 2016; 65 QM Anstee (10543_CR82) 2015; 35 XD Zhou (10543_CR10) 2022; 21 S Rüschenbaum (10543_CR85) 2018; 2 H Lee (10543_CR30) 2021; 19 J Yong (10543_CR65) 2022; 16 S Liu (10543_CR56) 2021; 120 A Albillos (10543_CR92) 2020; 72 P Paschos (10543_CR77) 2012; 4 10543_CR97 M Eslam (10543_CR110) 2020; 14 B Zou (10543_CR50) 2021; 66 TT Zou (10543_CR109) 2018; 30 S Wu (10543_CR21) 2016; 6 C von Loeffelholz (10543_CR114) 2021; 9 Y Liang (10543_CR31) 2022; 107 J Gutiérrez-Cuevas (10543_CR74) 2021; 22 V Ormazabal (10543_CR75) 2018; 17 H Zhang (10543_CR38) 2021; 134 VH Nguyen (10543_CR60) 2021; 19 F Baratta (10543_CR113) 2020; 12 Z Younossi (10543_CR1) 2016; 64 JH Moon (10543_CR52) 2022; 16 J Du (10543_CR152) 2014; 20 SK Kunutsor (10543_CR49) 2017; 466 M Eslam (10543_CR3) 2020; 73 A Mantovani (10543_CR80) 2021; 22 F Baratta (10543_CR42) 2020; 18 J Toh (10543_CR20) 2022; 20 W Wen (10543_CR32) 2022; 13 J Mehtälä (10543_CR144) 2019; 10 M Niriella (10543_CR36) 2021; 16 SJ Daniels (10543_CR46) 2019; 69 Y Chang (10543_CR116) 2019; 69 BA Rice (10543_CR117) 2022 C Reinhardt (10543_CR91) 2019; 39 VH Ajmera (10543_CR115) 2017; 65 T Tsutsumi (10543_CR27) 2021; 51 Y Fouad (10543_CR7) 2021; 41 D Ferro (10543_CR45) 2020; 12 VW Wong (10543_CR12) 2021; 19 H Attia (10543_CR78) 2022; 2022 J Bolinder (10543_CR138) 2012; 97 N Simons (10543_CR84) 2017; 152 HM den Ruijter (10543_CR101) 2013; 56 SM Grundy (10543_CR147) 2019; 139 A Srivastava (10543_CR105) 2019; 71 AJ Scheen (10543_CR134) 2020; 16 J Moon (10543_CR127) 2022; 33 KI Zheng (10543_CR14) 2021; 74 D Niederseer (10543_CR70) 2021; 10 Y Liu (10543_CR34) 2019; 9 Y Schonmann (10543_CR41) 2021; 53 LB VanWagner (10543_CR125) 2017; 153 ASP Tang (10543_CR53) 2022; 28 K Fatima (10543_CR150) 2021; 46 J Park (10543_CR51) 2022; 21 S Khoo (10543_CR151) 2020; 35 E Han (10543_CR44) 2022; 16 NWS Chew (10543_CR81) 2022; 13 XL Zhang (10543_CR4) 2022; 7 D Peng (10543_CR66) 2022; 13 S Sookoian (10543_CR83) 2011; 53 D Kim (10543_CR35) 2021; 75 MA Austin (10543_CR73) 1990; 82 B Hansel (10543_CR122) 2010; 64 TA Zelniker (10543_CR136) 2019; 139 F Rubino (10543_CR17) 2020; 26 EP Stahl (10543_CR69) 2019; 73 PN Newsome (10543_CR132) 2021; 384 A Mantovani (10543_CR140) 2020; 11 K Sung (10543_CR57) 2023; 43 ML Petroni (10543_CR111) 2021; 372 J Cai (10543_CR88) 2020; 126 M Yoneda (10543_CR29) 2021; 56 G Goh (10543_CR76) 2015; 35 XL Zhang (10543_CR108) 2022; 46 G Targher (10543_CR19) 2020; 69 F Li (10543_CR93) 2021; 20 S Harrison (10543_CR106) 2023; 29 LL Lai (10543_CR139) 2020; 65 G Targher (10543_CR18) 2010; 363 Y Zhou (10543_CR24) 2018; 2 T Wu (10543_CR102) 2021; 53 H Hu (10543_CR95) 2020; 55 AM Wood (10543_CR121) 2018; 391 V Ajmera (10543_CR118) 2018; 16 H Tilg (10543_CR9) 2020; 17 K Kashiwagi (10543_CR126) 2020; 89 TA Zelniker (10543_CR135) 2020; 75 NM Meyersohn (10543_CR48) 2021; 19 Q Anstee (10543_CR67) 2018; 15 LH Young (10543_CR142) 2017; 135 WHW Tang (10543_CR90) 2019; 73 K Nishimura (10543_CR39) 2016; 23 M Elsaid (10543_CR156) 2022; 5 |
| References_xml | – volume: 73 start-page: 202 year: 2020 ident: 10543_CR3 publication-title: J Hepatol doi: 10.1016/j.jhep.2020.03.039 – volume: 376 start-page: 1916 year: 2010 ident: 10543_CR149 publication-title: Lancet doi: 10.1016/S0140-6736(10)61272-X – volume: 152 start-page: 912 year: 2017 ident: 10543_CR84 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.12.020 – volume: 71 start-page: 371 year: 2019 ident: 10543_CR105 publication-title: J Hepatol doi: 10.1016/j.jhep.2019.03.033 – volume: 10 start-page: 849 year: 2021 ident: 10543_CR8 publication-title: Hepatobiliary Surg Nutr doi: 10.21037/hbsn-21-352 – volume: 18 start-page: 2324 year: 2020 ident: 10543_CR42 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.12.026 – volume: 14 year: 2022 ident: 10543_CR99 publication-title: Cureus – volume: 64 start-page: 561 year: 2010 ident: 10543_CR122 publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2010.61 – volume: 8 year: 2021 ident: 10543_CR26 publication-title: Front Med doi: 10.3389/fmed.2021.693507 – volume: 142 start-page: 711 year: 2012 ident: 10543_CR72 publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.02.003 – volume: 6 start-page: 33386 year: 2016 ident: 10543_CR21 publication-title: Sci Rep doi: 10.1038/srep33386 – volume: 20 start-page: 569 year: 2014 ident: 10543_CR152 publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i2.569 – volume: 120 start-page: 154779 year: 2021 ident: 10543_CR56 publication-title: Metabolism doi: 10.1016/j.metabol.2021.154779 – volume: 126 start-page: 679 year: 2020 ident: 10543_CR88 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.119.316337 – volume: 14 start-page: 103 year: 2021 ident: 10543_CR89 publication-title: Nutrients doi: 10.3390/nu14010103 – volume: 16 start-page: 433 year: 2022 ident: 10543_CR52 publication-title: Gut Liver doi: 10.5009/gnl210167 – volume: 326 start-page: 2031 year: 2021 ident: 10543_CR155 publication-title: JAMA doi: 10.1001/jama.2021.19569 – volume: 391 start-page: 1513 year: 2018 ident: 10543_CR121 publication-title: Lancet doi: 10.1016/S0140-6736(18)30134-X – volume: 69 start-page: 1691 year: 2020 ident: 10543_CR19 publication-title: Gut doi: 10.1136/gutjnl-2020-320622 – volume: 36 start-page: 2960 year: 2021 ident: 10543_CR43 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.15589 – volume: 149 start-page: 367 year: 2015 ident: 10543_CR153 publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.04.005 – volume: 42 start-page: 271 year: 2022 ident: 10543_CR11 publication-title: Liver Int doi: 10.1111/liv.15142 – volume: 75 start-page: 435 year: 2020 ident: 10543_CR135 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2019.11.036 – volume: 13 start-page: 935390 year: 2022 ident: 10543_CR66 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.935390 – volume: 64 start-page: 73 year: 2016 ident: 10543_CR1 publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.28431 – volume: 69 start-page: 2414 year: 2019 ident: 10543_CR128 publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.30320 – volume: 53 start-page: 385 year: 2021 ident: 10543_CR104 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2021.01.014 – volume: 73 start-page: 2089 year: 2019 ident: 10543_CR90 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2019.03.024 – volume: 12 start-page: 1732 year: 2020 ident: 10543_CR113 publication-title: Nutrients doi: 10.3390/nu12061732 – volume: 11 start-page: 73 year: 2021 ident: 10543_CR133 publication-title: Metabolites doi: 10.3390/metabo11020073 – year: 2022 ident: 10543_CR117 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2022.10.039 – volume: 13 start-page: 1007171 year: 2022 ident: 10543_CR62 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.1007171 – volume: 15 start-page: 357 year: 2019 ident: 10543_CR103 publication-title: Gastroenterol Hepatol (N Y) – volume: 20 start-page: 22 year: 2021 ident: 10543_CR93 publication-title: Lipids Health Dis doi: 10.1186/s12944-021-01440-w – volume: 5 year: 2022 ident: 10543_CR156 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.35003 – volume: 67 start-page: 4919 year: 2022 ident: 10543_CR25 publication-title: Dig Dis Sci doi: 10.1007/s10620-022-07508-6 – volume: 16 start-page: 1511 year: 2018 ident: 10543_CR118 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2018.01.026 – volume: 13 start-page: 968766 year: 2022 ident: 10543_CR28 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.968766 – volume: 112 start-page: 1832 year: 2017 ident: 10543_CR112 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2017.371 – volume: 35 start-page: 320 year: 2020 ident: 10543_CR151 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.14794 – volume: 13 start-page: 1000 year: 2015 ident: 10543_CR71 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2014.10.008 – volume: 19 start-page: 1480 year: 2021 ident: 10543_CR48 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.07.030 – volume: 76 start-page: 469 year: 2022 ident: 10543_CR79 publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.32294 – volume: 16 year: 2021 ident: 10543_CR36 publication-title: PLoS ONE doi: 10.1371/journal.pone.0245762 – volume: 59 start-page: 1245 year: 2010 ident: 10543_CR47 publication-title: Gut doi: 10.1136/gut.2009.203166 – volume: 16 start-page: 269 year: 2022 ident: 10543_CR65 publication-title: Hep Int doi: 10.1007/s12072-022-10319-6 – volume: 29 start-page: 562 year: 2023 ident: 10543_CR106 publication-title: Nat Med doi: 10.1038/s41591-023-02242-6 – volume: 21 start-page: 53 year: 2022 ident: 10543_CR51 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-022-01483-y – volume: 26 start-page: 485 year: 2020 ident: 10543_CR17 publication-title: Nat Med doi: 10.1038/s41591-020-0803-x – volume: 15 start-page: 425 year: 2018 ident: 10543_CR67 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-018-0010-0 – volume: 20 start-page: 2462 year: 2022 ident: 10543_CR20 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.09.021 – volume: 466 start-page: 54 year: 2017 ident: 10543_CR49 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2017.01.008 – volume: 17 start-page: 122 year: 2018 ident: 10543_CR75 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-018-0762-4 – volume: 74 start-page: 989 year: 2021 ident: 10543_CR14 publication-title: J Hepatol doi: 10.1016/j.jhep.2020.12.016 – volume: 23 start-page: 1138 year: 2016 ident: 10543_CR39 publication-title: J Atheroscler Thromb doi: 10.5551/jat.Er19356 – volume: 49 start-page: 300060521104707 year: 2021 ident: 10543_CR61 publication-title: J Int Med Res doi: 10.1177/03000605211047074 – volume: 82 start-page: 495 year: 1990 ident: 10543_CR73 publication-title: Circulation doi: 10.1161/01.CIR.82.2.495 – volume: 19 start-page: 2138 year: 2021 ident: 10543_CR30 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.12.022 – volume: 10 start-page: 467 year: 2021 ident: 10543_CR70 publication-title: J Clin Med doi: 10.3390/jcm10030467 – volume: 9 start-page: 11124 year: 2019 ident: 10543_CR34 publication-title: Sci Rep doi: 10.1038/s41598-019-47687-3 – volume: 13 start-page: 957245 year: 2022 ident: 10543_CR63 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.957245 – volume: 12 start-page: 2762 year: 2020 ident: 10543_CR45 publication-title: Nutrients doi: 10.3390/nu12092762 – volume: 11 start-page: 1847 year: 2022 ident: 10543_CR59 publication-title: J Clin Med doi: 10.3390/jcm11071847 – volume: 22 start-page: 2350 year: 2021 ident: 10543_CR80 publication-title: Int J Mol Sci doi: 10.3390/ijms22052350 – year: 2022 ident: 10543_CR37 publication-title: Gut doi: 10.1136/gutjnl-2022-328224 – volume: 12 year: 2022 ident: 10543_CR119 publication-title: BMJ Open doi: 10.1136/bmjopen-2021-049767 – volume: 17 start-page: 279 year: 2020 ident: 10543_CR94 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-020-0269-9 – volume: 5 year: 2022 ident: 10543_CR124 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.3849 – volume: 89 start-page: 1 year: 2020 ident: 10543_CR126 publication-title: Alcohol doi: 10.1016/j.alcohol.2020.07.010 – volume: 153 start-page: 1260 year: 2017 ident: 10543_CR125 publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.08.012 – volume: 53 start-page: 1883 year: 2011 ident: 10543_CR83 publication-title: Hepatology doi: 10.1002/hep.24283 – volume: 41 start-page: 1999 year: 2021 ident: 10543_CR107 publication-title: Liver Int doi: 10.1111/liv.15013 – volume: 6 start-page: 105 year: 2018 ident: 10543_CR130 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(17)30412-6 – ident: 10543_CR97 doi: 10.1016/j.jhep.2015.11.004 – volume: 53 start-page: 79 year: 2021 ident: 10543_CR41 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2020.10.014 – volume: 13 start-page: 934225 year: 2022 ident: 10543_CR32 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2022.934225 – volume: 134 start-page: 1593 year: 2021 ident: 10543_CR38 publication-title: Chin Med J doi: 10.1097/CM9.0000000000001513 – volume: 41 start-page: 255 year: 2021 ident: 10543_CR7 publication-title: Liver Int doi: 10.1111/liv.14739 – volume: 139 start-page: e1082 year: 2019 ident: 10543_CR147 publication-title: Circulation – volume: 158 start-page: 1999 year: 2020 ident: 10543_CR5 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.11.312 – volume: 363 start-page: 1341 year: 2010 ident: 10543_CR18 publication-title: N Engl J Med doi: 10.1056/NEJMra0912063 – volume: 7 start-page: 598 year: 2022 ident: 10543_CR4 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(22)00127-3 – volume: 372 year: 2021 ident: 10543_CR111 publication-title: BMJ doi: 10.1136/bmj.m4747 – volume: 115 year: 2021 ident: 10543_CR13 publication-title: Metabolism doi: 10.1016/j.metabol.2020.154433 – volume: 19 start-page: 60 year: 2022 ident: 10543_CR16 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-021-00523-4 – volume: 79 start-page: 180 year: 2022 ident: 10543_CR68 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2021.11.007 – volume: 138 start-page: 1210 year: 2018 ident: 10543_CR143 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.034763 – volume: 97 start-page: 1020 year: 2012 ident: 10543_CR138 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-2260 – volume: 127 start-page: 553 year: 2020 ident: 10543_CR96 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.120.316242 – volume: 53 start-page: 383 year: 2021 ident: 10543_CR40 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2020.12.123 – volume: 43 start-page: 482 year: 2023 ident: 10543_CR57 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.122.318661 – volume: 16 start-page: 556 year: 2020 ident: 10543_CR134 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-020-0392-2 – volume: 19 start-page: 2161 year: 2021 ident: 10543_CR12 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.10.046 – volume: 7 start-page: 776 year: 2019 ident: 10543_CR129 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30249-9 – volume: 73 start-page: 948 year: 2019 ident: 10543_CR69 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.11.050 – volume: 49 start-page: 1758 year: 2017 ident: 10543_CR86 publication-title: Nat Genet doi: 10.1038/ng.3977 – volume: 23 start-page: 1361 year: 2022 ident: 10543_CR15 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(22)00606-4 – volume: 2 start-page: 798 year: 2018 ident: 10543_CR85 publication-title: Hepatol Commun doi: 10.1002/hep4.1183 – volume: 5 start-page: 1412 year: 2021 ident: 10543_CR146 publication-title: Hepatol Commun doi: 10.1002/hep4.1723 – volume: 53 start-page: 1610 year: 2021 ident: 10543_CR102 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2021.02.003 – volume: 21 start-page: 270 year: 2022 ident: 10543_CR10 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-022-01697-0 – volume: 28 start-page: 483 year: 2022 ident: 10543_CR53 publication-title: Clin Mol Hepatol doi: 10.3350/cmh.2021.0406 – volume: 69 start-page: 64 year: 2019 ident: 10543_CR116 publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.30170 – volume: 65 start-page: 623 year: 2020 ident: 10543_CR139 publication-title: Dig Dis Sci doi: 10.1007/s10620-019-5477-1 – volume: 2022 start-page: 9479456 year: 2022 ident: 10543_CR78 publication-title: Oxid Med Cell Longev doi: 10.1155/2022/9479456 – volume: 69 start-page: 1075 year: 2019 ident: 10543_CR46 publication-title: Hepatology doi: 10.1002/hep.30163 – volume: 39 start-page: 173 year: 2019 ident: 10543_CR91 publication-title: Hamostaseologie doi: 10.1055/s-0038-1675357 – volume: 6 start-page: 578 year: 2021 ident: 10543_CR22 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(21)00020-0 – volume: 16 start-page: 786 year: 2022 ident: 10543_CR44 publication-title: Gut Liver doi: 10.5009/gnl210290 – volume: 56 start-page: 1494 year: 2013 ident: 10543_CR101 publication-title: Diabetologia doi: 10.1007/s00125-013-2898-9 – volume: 19 start-page: 2172 year: 2021 ident: 10543_CR60 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2021.05.029 – volume: 35 start-page: 270 year: 2015 ident: 10543_CR82 publication-title: Semin Liver Dis doi: 10.1055/s-0035-1562947 – volume: 4 start-page: 327 year: 2012 ident: 10543_CR77 publication-title: World J Hepatol doi: 10.4254/wjh.v4.i12.327 – volume: 384 start-page: 1113 year: 2021 ident: 10543_CR132 publication-title: N Engl J Med doi: 10.1056/NEJMoa2028395 – volume: 16 start-page: 714 year: 2022 ident: 10543_CR55 publication-title: Front Med doi: 10.1007/s11684-021-0888-8 – volume: 13 year: 2022 ident: 10543_CR81 publication-title: Front Genet doi: 10.3389/fgene.2022.971484 – volume: 11 start-page: 223 year: 2019 ident: 10543_CR145 publication-title: J Diabetes doi: 10.1111/1753-0407.12833 – volume: 324 start-page: 879 year: 2020 ident: 10543_CR154 publication-title: JAMA doi: 10.1001/jama.2020.12567 – volume: 66 start-page: 2092 year: 2021 ident: 10543_CR50 publication-title: Dig Dis Sci doi: 10.1007/s10620-021-06954-y – volume: 35 start-page: 979 year: 2015 ident: 10543_CR76 publication-title: Liver Int doi: 10.1111/liv.12611 – volume: 66 start-page: 467 year: 2019 ident: 10543_CR64 publication-title: Endocrine doi: 10.1007/s12020-019-02070-0 – volume: 133 start-page: 2271 year: 2020 ident: 10543_CR6 publication-title: Chin Med J doi: 10.1097/CM9.0000000000000981 – volume: 355 start-page: 2297 year: 2006 ident: 10543_CR141 publication-title: N Engl J Med doi: 10.1056/NEJMoa060326 – volume: 65 start-page: 589 year: 2016 ident: 10543_CR33 publication-title: J Hepatol doi: 10.1016/j.jhep.2016.05.013 – volume: 75 start-page: 1284 year: 2021 ident: 10543_CR35 publication-title: J Hepatol doi: 10.1016/j.jhep.2021.07.035 – volume: 139 start-page: 2022 year: 2019 ident: 10543_CR136 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.038868 – volume: 11 start-page: 22 year: 2020 ident: 10543_CR140 publication-title: Metabolites doi: 10.3390/metabo11010022 – volume: 135 start-page: 1882 year: 2017 ident: 10543_CR142 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.024863 – volume: 17 start-page: 387 year: 2020 ident: 10543_CR9 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-020-0316-6 – volume: 46 start-page: 391 year: 2022 ident: 10543_CR108 publication-title: Diabetes Metab J doi: 10.4093/dmj.2022.0048 – volume: 46 year: 2021 ident: 10543_CR150 publication-title: Clin Res Hepatol Gastroenterol doi: 10.1016/j.clinre.2021.101816 – volume: 387 start-page: 679 year: 2016 ident: 10543_CR131 publication-title: Lancet doi: 10.1016/S0140-6736(15)00803-X – volume: 2 start-page: 376 year: 2018 ident: 10543_CR24 publication-title: Hepatol Commun doi: 10.1002/hep4.1155 – volume: 9 start-page: 506 year: 2019 ident: 10543_CR98 publication-title: J Clin Exp Hepatol doi: 10.1016/j.jceh.2019.02.005 – volume: 72 start-page: 558 year: 2020 ident: 10543_CR92 publication-title: J Hepatol doi: 10.1016/j.jhep.2019.10.003 – volume: 51 start-page: 1115 year: 2021 ident: 10543_CR27 publication-title: Hepatol Res doi: 10.1111/hepr.13685 – volume: 56 start-page: 1022 year: 2021 ident: 10543_CR29 publication-title: J Gastroenterol doi: 10.1007/s00535-021-01828-6 – volume: 67 start-page: 328 year: 2018 ident: 10543_CR2 publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.29367 – volume: 5 start-page: e79 year: 2020 ident: 10543_CR100 publication-title: Arch Med Sci Atheroscler Dis doi: 10.5114/amsad.2020.95651 – volume: 9 start-page: 1853 year: 2021 ident: 10543_CR114 publication-title: Biomedicines doi: 10.3390/biomedicines9121853 – volume: 30 start-page: 747 year: 2018 ident: 10543_CR109 publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000001135 – volume: 88 start-page: 441 year: 2022 ident: 10543_CR148 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.14943 – volume: 17 year: 2022 ident: 10543_CR54 publication-title: PLoS ONE doi: 10.1371/journal.pone.0269265 – volume: 55 start-page: 1339 year: 2010 ident: 10543_CR120 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.01.006 – volume: 22 start-page: 11629 year: 2021 ident: 10543_CR74 publication-title: Int J Mol Sci doi: 10.3390/ijms222111629 – volume: 55 start-page: 142 year: 2020 ident: 10543_CR95 publication-title: J Gastroenterol doi: 10.1007/s00535-019-01649-8 – volume: 14 start-page: 889 year: 2020 ident: 10543_CR110 publication-title: Hepatol Int doi: 10.1007/s12072-020-10094-2 – volume: 15 start-page: 1337 year: 2021 ident: 10543_CR58 publication-title: Hep Int doi: 10.1007/s12072-021-10252-0 – volume: 65 start-page: 2090 year: 2017 ident: 10543_CR115 publication-title: Hepatology doi: 10.1002/hep.29055 – volume: 6 start-page: 903 year: 2021 ident: 10543_CR23 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(21)00308-3 – volume: 10 start-page: 24 year: 2019 ident: 10543_CR144 publication-title: Diabetol Int doi: 10.1007/s13340-018-0360-4 – volume: 28 start-page: 369 year: 2005 ident: 10543_CR123 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2005.01.011 – volume: 6 start-page: 610 year: 2021 ident: 10543_CR87 publication-title: JACC Basic Transl Sci doi: 10.1016/j.jacbts.2021.04.001 – volume: 33 start-page: 424 year: 2022 ident: 10543_CR127 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2022.03.005 – volume: 75 start-page: 422 year: 2020 ident: 10543_CR137 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2019.11.031 – volume: 107 start-page: 88 year: 2022 ident: 10543_CR31 publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab641 |
| SSID | ssib031263453 ssj0055616 |
| Score | 2.5989826 |
| Snippet | © Asian Pacific Association for the Study of the Liver 2023
Background: Fatty liver disease in the absence of excessive alcohol consumption is an increasingly... Background Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25–30% and is... Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also... BackgroundFatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25–30% and is... |
| SourceID | pubmedcentral hal proquest pubmed crossref springer rcaap nii |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 773 |
| SubjectTerms | [SDV]Life Sciences [q-bio] and Metabolism Asia associated fatty liver disease Cardiology Cardiovascular disease cardiovascular disease; consensus; delphi survey; mafld; metabolic (dysfunction)-associated fatty liver disease; non-alcoholic fatty liver diseas Cardiovascular Diseases CLINICAL MEDICINE Clinical Medicine (MED) Colorectal Surgery Consensus Dahili Tıp Bilimleri Delphi survey Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 Dyslipidemia Endocrinology Epidemiology Fatty liver Gastroenterology GASTROENTEROLOGY & HEPATOLOGY Gastroenterology and Hepatology GASTROENTEROLOJİ VE HEPATOLOJİ Gastroenteroloji-(Hepatoloji) Health risks Health Sciences Heart diseases Hepatology Hepatoloji Humans Internal Diseases Internal Medicine Sciences İç Hastalıkları Klinik Tıp Klinik Tıp (MED) Life Sciences Liver Liver Diseases MAFLD Medicine Medicine & Public Health Metabolic (dysfunction) Metabolic (dysfunction)-associated fatty liver disease Metabolism Non-alcoholic Fatty Liver Disease Pathogenesis Risk factors Sağlık Bilimleri SDG 3 - Good Health and Well-being Surgery Tıp |
| Title | An international multidisciplinary consensus statement on MAFLD and the risk of CVD |
| URI | https://cir.nii.ac.jp/crid/1871428067839517440 http://hdl.handle.net/10451/57576 https://link.springer.com/article/10.1007/s12072-023-10543-8 https://www.ncbi.nlm.nih.gov/pubmed/37204656 https://www.proquest.com/docview/2843573023 https://www.proquest.com/docview/2816766105 https://hal.sorbonne-universite.fr/hal-04214717 https://pubmed.ncbi.nlm.nih.gov/PMC10198034 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_RVUK8oPGdfVQG8QaR4sR2nMdoW1fBygsUlafISRyt0uROS8vfz52btKs2kHjJQ-xaV9_57ufcF8DHqDEIk3UU1k2kQ1GWKjQiq0OdKS0sKkOhKXd4-k1NZuLLXM67pLC2j3bvXZJeU--S3eIojUO0Mag6pEhCPYChpHpSKMWzOO_1L_V7VBtfMt6VEc10qTKPr7FnjgbXFAw5cIvFY3jzYdjk8K4y5vaBD9WbpvEhPO8wJcs3QvACnlj3Ep5OO6_5K_ieO7a4_-WP-TDC-wm5rKKoateuW-ZTjOibIVs6Ns3HV-fMuJohUGQUh86WDTv7ef4aZuOLH2eTsGumEFYqiVah5EY1KrNC16qU2lbcNFbUFZeVajLb2FiWsZJJzdF8JbXSqVZUCCYqm4ayLJM3cOCWzr4DJhBjcRPjZSitBK5hbKZNJVFdIfowMQ-A93taVF2lcWp4cVPsaiQTHwrkQ-H5UOgAPm1_c7ups_HP2R-QVduJVCJ7kl8V9A6VEEeDm_5GMk6Rk0gBPTleDAV5kfHPZVSdW0QBnPQ8LrqD2xZorROZUielAN5vh_HIkR_FOLtc0xzcI8Q1kQzg7UYktqT4pj-IkQPQe8KyR-v-iFtc-7LeqBwzHSUigCMvVwXFeSPPWxwRkhcIrFNc93MvbDui_75RR_83_RiexXQ4fIDjCRys7tb2FEHXqhzBML_89fViBIPLOR_5E_cH5MYdNw |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFH-irQRc-P7I2MAgbpApTmzHOVbbSmHtLqxonCzHcbQK5E5Ly4G_nud8tCsbSLvkEDvW88vLez_nfQG8j0qNMFlGYVFGMmR5LkLNsiKUmZDMojJk0ucOT0_EeMa-nPGzNims6qLdO5dkrak3yW5xlMYh2hhUHZwloezBgFEpeR8Gw0_fj486Dew7PorGm4ynZcQzbbLMzatsGaTeuQ-H7Ln5_CbEeT1wcnBptL645kWtjdPoIcy6bTUxKT_2V8t83_z-q-Ljbff9CB60aJUMG_F6DHesewJ3p60__il8HToyv_pPkdQBildTfYnx8dquWlWkTl7yfyPJwpHpcDQ5JNoVBCEo8RHuZFGSg2-Hz2A2Ojo9GIdtm4bQiCRahpxqUYrMMlmInEtrqC4tKwzlRpSZLW3M81jwpKBoGJNCyFQKX2ImysvS528mz6HvFs6-BMIQvVEd4zErNQzX0DaT2nBUhIhrdEwDoN27UqatYe5bafxUm-rLnlsKuaVqbikZwIf1MxdNBY__zn6HIrCe6Itvj4cT5e-heqNoytNfSMYeSghS4K8Uj5zM-6dxc5mv-82iAHY72VGtSqgU4oCEp75HUwBv18P4MXsPjXZ2sfJzkEeImCIewItG1Nak1O2EEH0HILeEcIvW7RE3P68LhqPazWSUsAB2anlVPoIc33mFI4xThZA9xXU_dvK3IfrfjNq53fQ3cG98Op2oyeeT41dwP_biXIdR7kJ_ebmyewjtlvnr9kv-A1FyOow |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfoJk28IL6XsYFBvEG0OLEd57FaqQq0ExIU7c1yElurhNxqbff3785J-qENJF7yELvW1Xe--zn3RcjHxBmAySqJa5eomJeljA0v6lgVUnELypArzB2eXMrRlH-7Elc7Wfwh2r1zSTY5DVilya_OF7U73ya-pUmexmBvQI0InsWqRw452GoM6pqm_U4XY-9H2fiV4d4MyKZNm3l4jT3T1LvGwMien80ewp73QygPbypjFvf8qcFMDZ-SJy2-pP1GIJ6RR9Y_J0eT1oP-gvzsezrb_QpIQ0jhbnIurTDC2i_XSxrSjfD7IZ17OukPxwNqfE0BNFKMSadzRy9-D16S6fDLr4tR3DZWiCuZJatYMCOdLCxXtSyFshUzzvK6YqKSrrDOpqJMpchqBqYsq6XKlcSiMEnpHGZcZq_IgZ97e0woB7zFTAoXo7zisIaxhTKVANUFSMSkLCKs21NdtVXHsfnFH72tl4x80MAHHfigVUQ-bX6zaGpu_HP2B2DVZiKWyx71xxrfgUJiYHzzWyDjDDgJFOCTwSWRo0cZ_lyBlbp5EpHTjse6PcRLDZY7Ezl2VYrI-80wHD_0qRhv52ucA3sEGCcREXndiMSGlNAACPByRNSesOzRuj_iZ9ehxDcoykIlGY_ISZArjTHfwPMljHDBNIDsHNb93Anblui_b9TJ_01_R45-DIZ6_PXy-xvyOMVzEuIeT8nB6mZtzwCLrcq34bjdAUqtIdo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+international+multidisciplinary+consensus+statement+on+MAFLD+and+the+risk+of+CVD&rft.jtitle=Hepatology+international&rft.au=Zhou%2C+Xiao-Dong&rft.au=Targher%2C+Giovanni&rft.au=Byrne%2C+Christopher+D&rft.au=Somers%2C+Virend&rft.date=2023-08-01&rft.issn=1936-0541&rft.eissn=1936-0541&rft.volume=17&rft.issue=4&rft.spage=773&rft_id=info:doi/10.1007%2Fs12072-023-10543-8&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-0533&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-0533&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-0533&client=summon |